Zacks5d agobullish
MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance RaisedMerit Medical's Q2 adjusted EPS jumps 18% as revenues rise 9.5%, margins expand and 2026 guidance increases after broad product growth.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
531last 24h
2513last 7d
483● bullish (7d)
258● bearish (7d)
197publishers
StockStory13d agobullish
West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock SoarsHealthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 13.8% year on year to $872.3 million. Guidance for next quarter’s revenue was better than expected at $827.5 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.37 per share was 13.9% above analysts’ consensus estimates.
Zacks61d agobullish
COO Stock Rises on Q2 Earnings Beat, FY26 Revenue Guidance TrimmedCooper Companies beats Q2 EPS and sales estimates as CooperVision and CooperSurgical hit record revenues, even with a GAAP loss from recall litigation.